-
While vaginitis usually is considered a minor nuisance, many women experience chronic symptoms that persist or recur after treatment. What can clinicians do?
-
Good news! Scientists have discovered two potent human antibodies that can neutralize more than 90% of known global HIV strains from infecting human cells in the laboratory, and they have demonstrated how one of these disease-fighting proteins achieves this action.
-
Your next patient is a recently divorced 48-year-old mother of two. Her menstrual periods have become somewhat irregular, and she reports occasional hot flashes and night sweats.
-
The search for a female-controlled form of HIV prevention just took a giant step. Results of a Phase IIB trial of a tenofovir gel indicate that use of the gel before and after sex provided moderate protection against sexually transmitted HIV.
-
Add Natazia, an estradiol valerate/dienogest pill, to the list of oral contraceptives approved by the Food and Drug Administration (FDA) and now available to U.S. women.
-
National medical organizations have issued positions on adolescent care will impact your practice. Add the following to the next clinical discussion at your facility:
-
As of September 2010, federal health reform legislation will require all new private health plans to provide coverage of a slate of preventive health services at no cost to patients. Will contraception be included in that coverage? Reproductive health advocates are calling for such measures.
-
When it comes to unplanned pregnancy and sexually transmitted diseases (STDs), young women, adolescents, and the poor often are the most at risk. However, women from all socioeconomic groups face challenges to their sexual and reproductive health.
-
What will it take to stem the incidence of HIV in the United States? According to the Centers for Disease Control and Prevention (CDC), about 56,300 people were newly infected with HIV in 2006, the most recent year for which data are available.
-
Check for use of erectile dysfunction (ED) drugs among older male patients; a new analysis of insurance records of more than 1.4 million U.S. men over 40 found that those who used ED drugs were more likely to have sexually transmitted diseases (STDs) than were non-users.
